货号	规格	价格	上海	北京	武汉	南京
S87785-1mg	99.6%	￥190.00 S87785-1mg ￥190.00 现货	10 10	-	-	-
S87785-5mg	99.6%	￥220.00 S87785-5mg ￥220.00 现货	6 6	-	-	-
S87785-10mg	99.6%	￥310.00 S87785-10mg ￥310.00 现货	6 6	-	-	-
S87785-25mg	99.6%	￥410.00 S87785-25mg ￥410.00 现货	6 6	-	-	-
S87785-50mg	≥98%	￥550.00 S87785-50mg ￥550.00 2-3天	0 货期：2-3天	-	-	-
S87785-100mg	≥98%	￥740.00 S87785-100mg ￥740.00 2-3天	0 货期：2-3天	-	-	-

大包装询价收藏产品

加入购物车

产品介绍

VU0155041 is a potent, selective positive allosteric modulator (PAM) of mGluR4, with EC50s of 798 nM and 693 nM for human and rat mGluR4, respectively. VU0155041 has potential for the research of Parkinson's disease (PD)

产品描述：

靶点：

Human mGlu4:798 nM (EC50);Rat mGlu4:693 nM (EC50);GluR

体内研究：

VU0155041 (31 nmol, 93 nmol; i.c.v.) reverses catalepsy induced by the dopamine D2 receptor antagonist Haloperidol (1.5 mg/kg, i.p.) in rats[1].VU0155041 (93 nnmol, 316 nmol; i.c.v.) reverses Reserpine (HY-N0480)-induced akinesia in rats. Animal Model: Third ventricle cannulated (TVC) Male Sprague-Dawley rats (225-255 g) Dosage: 31 nmol, 93 nmol (10 μL) Administration: Intracerebroventrical injection, after the Haloperidol (1.5 mg/kg) treatment 2 hours Result: Decreased the cataleptic effects of Haloperidol, and the effects still presented 30 min after infusion.

参考文献：

1. Niswender CM, et, al. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Mol Pharmacol. 2008 Nov; 74(5): 1345-58.

溶解性：

Soluble in DMSO

保存条件：

-20℃

配置溶液浓度参考：

	1mg	5mg	10mg
1 mM	3.163 ml	15.814 ml	31.628 ml
5 mM	0.633 ml	3.163 ml	6.326 ml
10 mM	0.316 ml	1.581 ml	3.163 ml
50 mM	0.063 ml	0.316 ml	0.633 ml

注意：

部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

参考文献

质检证书(COA)

输入产品批号：

如何获取质检证书(COA)?

请输入货号和一个与之匹配的批号。
例如:
批号：JS298415 货号：S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

质量

浓度

体积

分子摩尔量

计算重置

UV0155041

(±)-cis-2-(3,5-Dichlorophenylcarbamoy)cyclohexanecarboxylic Acid